In NSCLC, miR-21 is a serum biomarker for detection of early-stage NSCLC, and has been found to enhance cancer progression by targeting its targets genes, like SOCS1, PTEN, SOX7 [23–25]. This evidence concerns the gene SOX7 and non-small cell lung carcinoma.